Federated Hermes
HOWL icon

Federated Hermes’s Werewolf Therapeutics HOWL Stock Holding History

Federated Hermes’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,387
Closed -$2.78K – 2107
2025
Q4 		$2.78K Hold
4,387
– – ﹤0.01% 1947
2025
Q3 		$8.64K Hold
4,387
– – ﹤0.01% 1896
2025
Q2 		$4.78K Sell
4,387
-1,743
-28% -$1.79K ﹤0.01% 1891
2025
Q1 		$5.96K Buy
6,130
+5,716
+1,381% +$7.49K ﹤0.01% 1858
2024
Q4 		$613 Buy
+414
New +$844 ﹤0.01% 2036

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Federated Hermes's HOWL Position: Q1 2026 in Review

Federated Hermes sold out of Werewolf Therapeutics (HOWL) in Q1 2026, closing a stake of 4,387 shares — an estimated $2.78K sold.

Federated Hermes first reported a position in HOWL in Q4 2024 and held it in 5 quarters. The position peaked at $8.64K in Q3 2025. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Federated Hermes reported no remaining Werewolf Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Federated Hermes sold 4,387 Werewolf Therapeutics shares in Q1 2026, an estimated $2.78K.
  • Federated Hermes first reported a position in Werewolf Therapeutics in Q4 2024 and held it in 5 quarters.
  • Federated Hermes's Werewolf Therapeutics position peaked at $8.64K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.